| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.08 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.08 |